West Pharmaceutical Services Inc (WST)
320.88
+9.22
(+2.96%)
USD |
NYSE |
Nov 21, 16:00
325.19
+4.31
(+1.34%)
Pre-Market: 09:02
West Pharmaceutical Services Profit Margin (Quarterly): 18.21% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.21% |
| June 30, 2024 | 15.85% |
| March 31, 2024 | 16.58% |
| December 31, 2023 | 18.72% |
| September 30, 2023 | 21.58% |
| June 30, 2023 | 20.58% |
| March 31, 2023 | 19.54% |
| December 31, 2022 | 14.53% |
| September 30, 2022 | 17.56% |
| June 30, 2022 | 24.44% |
| March 31, 2022 | 24.14% |
| December 31, 2021 | 20.21% |
| September 30, 2021 | 24.85% |
| June 30, 2021 | 25.88% |
| March 31, 2021 | 22.54% |
| December 31, 2020 | 16.96% |
| September 30, 2020 | 15.02% |
| June 30, 2020 | 17.30% |
| March 31, 2020 | 15.12% |
| December 31, 2019 | 13.58% |
| September 30, 2019 | 12.34% |
| June 30, 2019 | 14.07% |
| March 31, 2019 | 12.49% |
| December 31, 2018 | 12.31% |
| September 30, 2018 | 12.79% |
| Date | Value |
|---|---|
| June 30, 2018 | 12.54% |
| March 31, 2018 | 10.49% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 12.81% |
| June 30, 2017 | 9.76% |
| March 31, 2017 | 15.71% |
| December 31, 2016 | 10.23% |
| September 30, 2016 | 9.98% |
| June 30, 2016 | 11.52% |
| March 31, 2016 | 6.10% |
| December 31, 2015 | 9.29% |
| September 30, 2015 | 0.44% |
| June 30, 2015 | 7.73% |
| March 31, 2015 | 9.79% |
| December 31, 2014 | 8.98% |
| September 30, 2014 | 8.71% |
| June 30, 2014 | 10.19% |
| March 31, 2014 | 7.81% |
| December 31, 2013 | 6.89% |
| September 30, 2013 | 7.84% |
| June 30, 2013 | 8.77% |
| March 31, 2013 | 9.34% |
| December 31, 2012 | 6.56% |
| September 30, 2012 | 4.87% |
| June 30, 2012 | 4.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
13.58%
Minimum
Dec 2019
25.88%
Maximum
Jun 2021
19.16%
Average
18.46%
Median
Profit Margin (Quarterly) Benchmarks
| Repligen Corp | -0.42% |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -18.58% |
| Xtant Medical Holdings Inc | -17.98% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.16% |
| Return on Assets | 13.61% |
| Return on Invested Capital | 16.89% |
| Gross Profit Margin (Quarterly) | 35.44% |
| Operating Margin (Quarterly) | 22.18% |
| Return on Net Operating Assets | 18.53% |